SAR and Molecular Modeling of N-Benzyl-N-hydroxy-3-(cyclopentyloxy)-4- methoxybenzene Carboxamide Analogues as Potent Phosphodiesterase-4 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|1|1|19-23

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.1, Iss.1, 2004-01, pp. : 19-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 4 inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 385-387

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 11, 1997-11 ,pp. : 1355-1357

Informa Healthcare

Access to resources Recommend Favorite

3D-QSAR, Molecular Docking and Molecular Dynamics Studies of 2,4- Diarylaminopyrimidine Analogues (DAAP Analogues) as Potent ALK Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 3, 2017-01 ,pp. : 270-286

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR study on N- (Aryl)-4-(Azolylethyl) Thiazole-5-Carboxamides: Novel Potent Inhibitors of VEGF Receptors I and II

By  

Medicinal Chemistry, Vol. 5, Iss. 5, 2009-09 ,pp. : 455-461

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors for the treatment of asthma

By Karlsson J-A.   Aldous D.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 989-1003

Informa Healthcare

Access to resources Recommend Favorite